MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• MicroRNAs (miRNAs) are key post-transcriptional regulators in cellular processes.
• Mechanisms of miRNA involvement in non-small cell lung cancer (NSCLC) chemosensitivity and metastasis require further elucidation.

Purpose of the Study:

• To identify the role and mechanism of miR-181b in NSCLC chemosensitivity and metastasis.
• To investigate the relationship between miR-181b, TGFβR1, and the TGFβR1/Smad signaling pathway.

Main Methods:

• Comparative analysis of miR-181b expression in NSCLC cell lines (A549 vs. A549/DDP).
• Functional assays (in vitro and in vivo) to assess the impact of miR-181b overexpression on proliferation, chemosensitivity, migration, and metastasis.
• Identification and validation of TGFβR1 as a direct target of miR-181b.
• Analysis of TGFβR1/Smad signaling pathway activity.
• Correlation analysis of miR-181b and TGFβR1 expression with clinical data from NSCLC patients.

Main Results:

• miR-181b expression was significantly lower in DDP-resistant NSCLC cells (A549/DDP) compared to sensitive cells (A549).
• Overexpression of miR-181b inhibited NSCLC cell proliferation, enhanced DDP chemosensitivity, and reduced migration and metastasis.
• TGFβR1 was confirmed as a direct target of miR-181b, and its modulation mimicked or reversed miR-181b's effects.
• miR-181b inactivated the TGFβR1/Smad signaling pathway.
• Decreased miR-181b and increased TGFβR1 expression correlated with DDP resistance and metastasis in NSCLC patients.

Conclusions:

• miR-181b functions as a tumor suppressor in NSCLC.
• miR-181b regulates NSCLC proliferation, chemosensitivity to DDP, and metastasis by targeting the TGFβR1/Smad signaling pathway.
• miR-181b represents a potential therapeutic target for overcoming DDP resistance and metastasis in NSCLC.